Target- |
MechanismGene transference |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
An Open Multicenter Study of the Safety, Tolerability, and Pharmacokinetics of Different Doses of Stimotimagene Copolymerplasmid at Patients With Advanced-stage Solid Tumors With Cymeven® (Ganciclovir) Infusions
The purpose of this study is to evaluate the safety and tolerability of different doses and administration regimens of Stimotimagene copolymerplasmid in patients with histologically confirmed diagnosis of solid tumor and/or its metastases.
100 Clinical Results associated with Gene Surgery LLC
0 Patents (Medical) associated with Gene Surgery LLC
100 Deals associated with Gene Surgery LLC
100 Translational Medicine associated with Gene Surgery LLC